Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Immuneering Corp (IMRX) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Immuneering Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 1790340.
Total stock buying since 2021: $19,100,918.
Total stock sales since 2021: $4,455,782.
Total stock option exercises since 2021: $19,564.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 127,507 | $334,059 | 0 | $0 | 0 | $0 |
| 2024 | 197,083 | $492,981 | 1,309,091 | $4,455,782 | 0 | $0 |
| 2022 | 29,168 | $176,802 | 0 | $0 | 6,500 | $19,564 |
| 2021 | 1,199,794 | $18,097,076 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 16,200 | $57,231 | 0 | $0 | 0 | $0 |
| 2025-06 | 111,307 | $276,828 | 0 | $0 | 0 | $0 |
| 2024-04 | 0 | $0 | 400,000 | $1,203,600 | 0 | $0 |
| 2024-03 | 197,083 | $492,981 | 909,091 | $3,252,182 | 0 | $0 |
| 2022-12 | 0 | $0 | 0 | $0 | 2,500 | $7,524 |
| 2022-05 | 11,551 | $54,299 | 0 | $0 | 0 | $0 |
| 2022-04 | 0 | $0 | 0 | $0 | 2,000 | $6,020 |
| 2022-03 | 17,617 | $122,503 | 0 | $0 | 0 | $0 |
| 2022-02 | 0 | $0 | 0 | $0 | 2,000 | $6,020 |
| 2021-09 | 12,932 | $294,146 | 0 | $0 | 0 | $0 |
| 2021-08 | 1,186,862 | $17,802,930 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-02 | Neufeld Leah R (CHIEF PEOPLE OFFICER) | Buy | 700 | 3.57 | 2,499 |
| 2025-07-02 | Zeskind Benjamin J. (PRESIDENT AND CEO) | Buy | 7,015 | 3.53 | 24,791 |
| 2025-07-02 | Hausman Diana | Buy | 5,500 | 3.61 | 19,855 |
| 2025-07-01 | Zeskind Benjamin J. (PRESIDENT AND CEO) | Buy | 2,985 | 3.38 | 10,086 |
| 2025-06-27 | Schall Thomas J. (Director) | Buy | 9,500 | 3.66 | 34,789 |
| 2025-06-23 | Hall Brett Matthew (CHIEF SCIENTIFIC OFFICER) | Buy | 6,007 | 2.43 | 14,597 |
| 2025-06-20 | Brakewood Harold Eugene (Chief Business Officer) | Buy | 1,900 | 2.53 | 4,805 |
| 2025-06-20 | Hall Brett Matthew (CHIEF SCIENTIFIC OFFICER) | Buy | 7,415 | 2.70 | 20,020 |
| 2025-06-18 | Feinberg Peter | Buy | 25,000 | 2.53 | 63,200 |
| 2025-06-18 | Zeskind Benjamin J. (PRESIDENT AND CEO) | Buy | 21,000 | 2.39 | 50,148 |
| 2025-06-17 | Schall Thomas J. (Director) | Buy | 40,485 | 2.21 | 89,269 |
| 2024-04-01 | Cormorant Private Healthcare Fund Iii Lp | Sale | 400,000 | 3.01 | 1,203,600 |
| 2024-03-22 | Brakewood Harold Eugene (Chief Business Officer) | Buy | 3,900 | 2.57 | 10,015 |
| 2024-03-22 | Morales Mallory (Chief Accounting Officer) | Buy | 393 | 2.55 | 1,000 |
| 2024-03-22 | Feinberg Peter | Buy | 25,000 | 2.55 | 63,725 |
| 2024-03-22 | Schall Thomas J. | Buy | 2,900 | 2.55 | 7,386 |
| 2024-03-21 | Morales Mallory (Chief Accounting Officer) | Buy | 1,107 | 2.72 | 3,008 |
| 2024-03-20 | Neufeld Leah R (CHIEF PEOPLE OFFICER) | Buy | 3,818 | 2.88 | 10,992 |
| 2024-03-20 | Hall Brett Matthew (CHIEF SCIENTIFIC OFFICER) | Buy | 7,000 | 2.86 | 20,020 |
| 2024-03-19 | Feinberg Peter | Buy | 25,000 | 2.56 | 64,000 |
| 2024-03-19 | Zeskind Benjamin J. (PRESIDENT AND CEO) | Buy | 20,000 | 2.77 | 55,320 |
| 2024-03-18 | Feinberg Peter | Buy | 50,000 | 2.68 | 134,050 |
| 2024-03-18 | Berman Ann E | Buy | 57,965 | 2.13 | 123,465 |
| 2024-03-15 | Cormorant Private Healthcare Fund Iii Lp | Sale | 400,000 | 2.14 | 856,400 |
| 2024-03-14 | Cormorant Private Healthcare Fund Iii Lp | Sale | 509,091 | 4.71 | 2,395,782 |
| 2022-12-22 | Zeskind Benjamin J. (PRESIDENT AND CEO) | Option Ex | 2,500 | 3.01 | 7,524 |
| 2022-05-25 | Hall Brett Matthew (CHIEF SCIENTIFIC OFFICER) | Buy | 2,551 | 3.92 | 9,999 |
| 2022-05-17 | Bookman Michael (GENERAL COUNSEL AND SECRETARY) | Buy | 1,000 | 4.88 | 4,880 |
| 2022-05-16 | Keating Laurie | Buy | 7,000 | 5.00 | 35,000 |
| 2022-05-12 | Amin Biren (CFO, TREASURER) | Buy | 1,000 | 4.42 | 4,420 |
| 2022-04-12 | Zeskind Benjamin J. (PRESIDENT AND CEO) | Option Ex | 2,000 | 3.01 | 6,020 |
| 2022-03-23 | Hall Brett Matthew (CHIEF SCIENTIFIC OFFICER) | Buy | 1,050 | 7.91 | 8,305 |
| 2022-03-23 | Zeskind Benjamin J. (PRESIDENT AND CEO) | Buy | 3,000 | 8.02 | 24,060 |
| 2022-03-22 | Barrett Scott (CHIEF MEDICAL OFFICER) | Buy | 900 | 7.49 | 6,736 |
| 2022-03-15 | Feinberg Peter | Buy | 6,667 | 6.75 | 45,002 |
| 2022-03-15 | Berman Ann E | Buy | 6,000 | 6.40 | 38,400 |
| 2022-02-28 | Zeskind Benjamin J. (PRESIDENT AND CEO) | Option Ex | 2,000 | 3.01 | 6,020 |
| 2021-09-20 | Feinberg Peter | Buy | 4,750 | 24.45 | 116,113 |
| 2021-09-13 | Feinberg Peter | Buy | 6,099 | 21.38 | 130,402 |
| 2021-09-13 | Zeskind Benjamin J. (PRESIDENT AND CEO) | Buy | 2,083 | 22.87 | 47,631 |
| 2021-08-03 | Hall Brett Matthew (Chief Scientific Officer) | Buy | 1,353 | 15.00 | 20,295 |
| 2021-08-03 | Amin Biren (CFO, Treasurer) | Buy | 4,175 | 15.00 | 62,625 |
| 2021-08-03 | Feinberg Peter | Buy | 291,667 | 15.00 | 4,375,005 |
| 2021-08-03 | Zeskind Benjamin J. (President and CEO) | Buy | 2,098 | 15.00 | 31,470 |
| 2021-08-03 | Barrett Scott (Chief Medical Officer) | Buy | 667 | 15.00 | 10,005 |
| 2021-08-03 | Bookman Michael (General Counsel and Secretary) | Buy | 1,402 | 15.00 | 21,030 |
| 2021-08-03 | Cormorant Private Healthcare Fund Iii Lp | Buy | 550,000 | 15.00 | 8,250,000 |
| 2021-08-03 | Keating Laurie | Buy | 7,000 | 15.00 | 105,000 |
| 2021-08-03 | Berman Ann E | Buy | 3,500 | 15.00 | 52,500 |
| 2021-08-03 | Carpenter Robert J | Buy | 325,000 | 15.00 | 4,875,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of IMRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Immuneering Corp (symbol IMRX, CIK number 1790340) see the Securities and Exchange Commission (SEC) website.